結果ページ2 国：ドイツ 取引所：Frankfurt セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
Frankfurt (648)
- {{item.name}}
- 全取引所
- Dusseldorf (1)
- Frankfurt (648)
- Munich (27)
- Stuttgart (39)
- XETRA (24)
バイオテクノロジー (648)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Celldex Therapeutics, Inc. TCE2.F | €21.80 23.83 USD |
+9
|
€1.48B 1.62B USD | €1.00 1.09 USD | €21.80 23.83 USD | €21.80 23.83 USD | €1.48B 1.62B USD | 0 | -€2.91 -3.1 USD | ||
| Ascletis Pharma Inc. 2VJ.F | €1.49 1.63 USD |
+1.36
|
€1.48B 1.61B USD | €503.00 549.85 USD | €1.46 1.6 USD | €1.49 1.63 USD | €1.48B 1.61B USD | 0 | -€0.03 -0.03 USD | ||
| Precigen, Inc. I5X.F | €4.03 4.41 USD |
+24.98
|
€1.47B 1.61B USD | €2.83K 3.09K USD | €4.03 4.41 USD | €4.03 4.41 USD | €1.47B 1.61B USD | 0 | -€1.22 -1.3 USD | ||
| Oxford Nanopore Technologies plc 4R0.F | €1.45 1.58 USD |
-0.14
|
€1.47B 1.6B USD | €7.00 7.65 USD | €1.42 1.56 USD | €1.45 1.59 USD | €1.47B 1.6B USD | 0 | -€0.17 -0.1 USD | ||
| Innoviva, Inc. HVE.F | €19.00 20.77 USD |
-0.52
|
€1.42B 1.56B USD | €62.00 67.77 USD | €19.00 20.77 USD | €19.00 20.77 USD | €1.42B 1.56B USD | 13.28 | €1.43 1.56 USD | ||
| Biotest Aktiengesellschaft BIO3.F | €30.20 33.01 USD |
+1.34
|
€1.40B 1.53B USD | €600.00 655.88 USD | €29.60 32.36 USD | €30.20 33.01 USD | €1.40B 1.53B USD | 0 | -€0.63 -0.6 USD | ||
| Biotest Aktiengesellschaft BIO.F | €42.20 46.13 USD |
0
|
€1.40B 1.53B USD | €30.00 32.79 USD | €42.20 46.13 USD | €42.20 46.13 USD | €1.40B 1.53B USD | 0 | -€0.63 -0.6 USD | ||
| MannKind Corporation NNFN.F | €4.30 4.7 USD |
+1.49
|
€1.36B 1.49B USD | €499.00 545.47 USD | €4.30 4.7 USD | €4.30 4.7 USD | €1.36B 1.49B USD | 47.72 | €0.09 0.1 USD | ||
| Pharvaris N.V. 9EN.F | €19.90 21.75 USD |
-1.49
|
€1.34B 1.46B USD | €30.00 32.79 USD | €19.90 21.75 USD | €19.90 21.75 USD | €1.34B 1.46B USD | 0 | -€2.90 -3.1 USD | ||
| Stoke Therapeutics, Inc. 0GT.F | €23.00 25.14 USD |
+3.6
|
€1.33B 1.45B USD | €233.00 254.7 USD | €23.00 25.14 USD | €23.00 25.14 USD | €1.33B 1.45B USD | 39.65 | €0.58 0.63 USD | ||
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | €3.02 3.3 USD |
-0.66
|
€1.31B 1.43B USD | €1.00 1.09 USD | €3.02 3.3 USD | €3.02 3.3 USD | €1.31B 1.43B USD | 14.38 | €0.21 0.23 USD | ||
| Pharma Mar, S.A. PMRA.F | €75.35 82.37 USD |
+0.33
|
€1.30B 1.42B USD | €100.00 109.31 USD | €75.35 82.37 USD | €75.35 82.37 USD | €1.30B 1.42B USD | 38.64 | €1.95 2.13 USD | ||
| BioCryst Pharmaceuticals, Inc. BO1.F | €6.01 6.57 USD |
+3.09
|
€1.29B 1.41B USD | €50.00 54.66 USD | €6.01 6.57 USD | €6.01 6.57 USD | €1.29B 1.41B USD | 0 | -€0.04 -0.04 USD | ||
| HBM Holdings Limited 6XY.F | €1.50 1.64 USD |
+2.04
|
€1.28B 1.4B USD | €619.00 676.65 USD | €1.49 1.63 USD | €1.50 1.64 USD | €1.28B 1.4B USD | 18.75 | €0.08 0.09 USD | ||
| Atai Beckley N.V. 9VC.F | €3.51 3.83 USD |
-1.24
|
€1.28B 1.4B USD | €20.00 21.86 USD | €3.43 3.75 USD | €3.51 3.83 USD | €1.28B 1.4B USD | 0 | -€0.71 -0.7 USD | ||
| Syndax Pharmaceuticals, Inc. 1T3.F | €12.40 13.55 USD |
0
|
€1.25B 1.37B USD | €4.43K 4.84K USD | €12.40 13.55 USD | €12.40 13.55 USD | €1.25B 1.37B USD | 0 | -€3.10 -3.3 USD | ||
| Ardelyx, Inc. 41X.F | €4.99 5.46 USD |
+0.6
|
€1.23B 1.34B USD | €200.00 218.63 USD | €4.99 5.46 USD | €4.99 5.46 USD | €1.23B 1.34B USD | 0 | -€0.20 -0.2 USD | ||
| Wave Life Sciences Ltd. 1U5.F | €6.40 7 USD |
+18.52
|
€1.14B 1.25B USD | €570.00 623.09 USD | €5.80 6.34 USD | €6.40 7 USD | €1.14B 1.25B USD | 0 | -€0.56 -0.6 USD | ||
| Immatics N.V. 4A3.F | €8.67 9.48 USD |
+2.3
|
€1.07B 1.17B USD | €750.00 819.85 USD | €8.67 9.48 USD | €8.67 9.48 USD | €1.07B 1.17B USD | 0 | -€0.57 -0.6 USD | ||
| ORIC Pharmaceuticals, Inc. 4TZ.F | €10.70 11.7 USD |
+3.88
|
€1.06B 1.16B USD | €1.00K 1.09K USD | €10.70 11.7 USD | €10.70 11.7 USD | €1.06B 1.16B USD | 0 | -€1.47 -1.6 USD | ||
| CK Life Sciences Int'l., (Holdings) Inc. LSI.F | €0.09 0.1 USD |
-2.07
|
€1.06B 1.15B USD | €0.00 0 USD | €0.09 0.1 USD | €0.09 0.1 USD | €1.06B 1.15B USD | 0 | €0.00 0 USD | ||
| Maravai LifeSciences Holdings, Inc. MAR.F | €3.10 3.39 USD |
+0.65
|
€1.03B 1.13B USD | €40.00 43.73 USD | €3.10 3.39 USD | €3.10 3.39 USD | €1.03B 1.13B USD | 0 | -€0.72 -0.7 USD | ||
| MedinCell S.A. MEB.F | €30.24 33.06 USD |
+1.34
|
€1.03B 1.13B USD | €200.00 218.63 USD | €29.92 32.71 USD | €30.28 33.1 USD | €1.03B 1.13B USD | 0 | -€0.62 -0.6 USD | ||
| AbCellera Biologics Inc. 8QQ.F | €3.43 3.75 USD |
+8.89
|
€1.03B 1.12B USD | €1.00K 1.09K USD | €3.22 3.52 USD | €3.43 3.75 USD | €1.03B 1.12B USD | 0 | -€0.49 -0.5 USD | ||
| Xeris Biopharma Holdings, Inc. 2B30.F | €6.12 6.68 USD |
-1.37
|
€1.03B 1.12B USD | €1.44K 1.58K USD | €6.12 6.68 USD | €6.12 6.68 USD | €1.03B 1.12B USD | 0 | -€0.09 -0.09 USD | ||
| Pharming Group N.V. PHG.F | €10.90 11.92 USD |
0
|
€1.02B 1.12B USD | €0.00 0 USD | €10.90 11.92 USD | €10.90 11.92 USD | €1.02B 1.12B USD | 0 | €0.00 0 USD | ||
| Pharming Group N.V. PHGN.F | €1.44 1.57 USD |
-1.97
|
€1.00B 1.09B USD | €7.00 7.65 USD | €1.44 1.57 USD | €1.44 1.57 USD | €1.00B 1.09B USD | 0 | €0.00 0 USD | ||
| Novavax, Inc. NVV1.F | €6.10 6.67 USD |
+0.08
|
€991.24M 1.08B USD | €250.00 273.28 USD | €6.00 6.56 USD | €6.10 6.67 USD | €991.24M 1.08B USD | 3.52 | €1.73 1.89 USD | ||
| Abbisko Cayman Limited 8ZD.F | €1.50 1.64 USD |
-11.24
|
€989.63M 1.08B USD | €690.00 754.26 USD | €1.50 1.64 USD | €1.50 1.64 USD | €989.63M 1.08B USD | 50.00 | €0.03 0.03 USD | ||
| UroGen Pharma Ltd. UR8.F | €20.00 21.86 USD |
0
|
€965.99M 1.06B USD | €190.00 207.7 USD | €20.00 21.86 USD | €20.00 21.86 USD | €965.99M 1.06B USD | 0 | -€2.98 -3.2 USD | ||
| Xencor, Inc. XE9.F | €12.50 13.66 USD |
+8.7
|
€936.86M 1.02B USD | €80.00 87.45 USD | €12.50 13.66 USD | €12.50 13.66 USD | €936.86M 1.02B USD | 0 | -€1.49 -1.6 USD | ||
| Nanobiotix S.A. 5NR.F | €18.48 20.2 USD |
+7.82
|
€923.25M 1.01B USD | €200.00 218.63 USD | €18.26 19.96 USD | €18.48 20.2 USD | €923.25M 1.01B USD | 0 | -€1.09 -1.1 USD | ||
| Nanobiotix S.A. 5NRA.F | €18.30 20 USD |
+7.65
|
€921.79M 1.01B USD | €10.00 10.93 USD | €17.80 19.46 USD | €18.30 20 USD | €921.79M 1.01B USD | 0 | -€1.09 -1.1 USD | ||
| CStone Pharmaceuticals PH4.F | €0.62 0.68 USD |
-6.06
|
€905.88M 990.25M USD | €5.00K 5.47K USD | €0.62 0.68 USD | €0.63 0.69 USD | €905.88M 990.25M USD | 0 | -€0.04 -0.04 USD | ||
| Iovance Biotherapeutics, Inc. 2LB.F | €2.12 2.32 USD |
+8.62
|
€896.50M 979.99M USD | €3.00K 3.28K USD | €2.12 2.32 USD | €2.12 2.32 USD | €896.50M 979.99M USD | 0 | -€1.02 -1.1 USD | ||
| Kodiak Sciences Inc. K27.F | €16.47 18 USD |
+3.91
|
€893.58M 976.8M USD | €284.00 310.45 USD | €16.47 18 USD | €16.47 18 USD | €893.58M 976.8M USD | 0 | -€3.26 -3.5 USD | ||
| Intellia Therapeutics, Inc. 38I.F | €7.60 8.31 USD |
+2.01
|
€883.86M 966.18M USD | €400.00 437.25 USD | €7.60 8.31 USD | €7.60 8.31 USD | €883.86M 966.18M USD | 0 | -€3.65 -3.9 USD | ||
| EyePoint Pharmaceuticals, Inc. PV3B.F | €9.88 10.8 USD |
+3.89
|
€854.09M 933.64M USD | €66.00 72.15 USD | €9.85 10.77 USD | €9.88 10.8 USD | €854.09M 933.64M USD | 0 | -€2.58 -2.8 USD | ||
| Palvella Therapeutics Inc. R PI6.F | €71.50 78.16 USD |
+2.14
|
€846.31M 925.13M USD | €1.00 1.09 USD | €71.50 78.16 USD | €71.50 78.16 USD | €846.31M 925.13M USD | 0 | -€2.51 -2.7 USD | ||
| Oxford Biomedica plc OXOA.F | €6.70 7.32 USD |
0
|
€826.98M 904M USD | €250.00 273.28 USD | €6.70 7.32 USD | €6.70 7.32 USD | €826.98M 904M USD | 0 | -€0.41 -0.4 USD | ||
| GNI Group Ltd. 3G6.F | €14.30 15.63 USD |
+5.93
|
€825.24M 902.1M USD | €500.00 546.57 USD | €14.30 15.63 USD | €14.30 15.63 USD | €825.24M 902.1M USD | 0 | -€0.02 -0.02 USD | ||
| Ocumension Therapeutics 5DG.F | €0.93 1.01 USD |
+1.09
|
€791.23M 864.92M USD | €625.00 683.21 USD | €0.92 1.01 USD | €0.93 1.01 USD | €791.23M 864.92M USD | 0 | -€0.04 -0.04 USD | ||
| CorMedix Inc. 19KA.F | €9.50 10.38 USD |
+3.83
|
€791.15M 864.83M USD | €1.00K 1.09K USD | €9.50 10.38 USD | €9.50 10.38 USD | €791.15M 864.83M USD | 5.00 | €1.90 2.08 USD | ||
| Theravance Biopharma, Inc. 0TB.F | €15.20 16.62 USD |
0
|
€784.73M 857.82M USD | €115.00 125.71 USD | €14.90 16.29 USD | €15.20 16.62 USD | €784.73M 857.82M USD | 31.02 | €0.49 0.54 USD | ||
| GH Research PLC 1KA.F | €11.70 12.79 USD |
+2.63
|
€753.56M 823.74M USD | €13.00 14.21 USD | €11.70 12.79 USD | €11.70 12.79 USD | €753.56M 823.74M USD | 0 | -€0.63 -0.6 USD | ||
| Arbutus Biopharma Corporation I9DN.F | €3.86 4.22 USD |
-1.28
|
€746.95M 816.52M USD | €4.50K 4.92K USD | €3.86 4.22 USD | €3.86 4.22 USD | €746.95M 816.52M USD | 0 | -€0.20 -0.2 USD | ||
| Savara Inc. YB4P.F | €3.64 3.98 USD |
-0.55
|
€743.72M 812.99M USD | €279.00 304.98 USD | €3.64 3.98 USD | €3.64 3.98 USD | €743.72M 812.99M USD | 0 | -€0.46 -0.5 USD | ||
| Raspberry Pi Holdings PLC R 0IK.F | €3.79 4.14 USD |
+0.26
|
€741.55M 810.62M USD | €350.00 382.6 USD | €3.78 4.13 USD | €3.82 4.18 USD | €741.55M 810.62M USD | 94.75 | €0.04 0.04 USD | ||
| Replimune Group, Inc. 7R8.F | €7.65 8.36 USD |
+6.25
|
€645.72M 705.86M USD | €200.00 218.63 USD | €7.65 8.36 USD | €7.65 8.36 USD | €645.72M 705.86M USD | 0 | -€2.98 -3.2 USD | ||
| Geron Corporation GON.F | €0.98 1.07 USD |
-0.71
|
€628.86M 687.43M USD | €1.00K 1.09K USD | €0.98 1.07 USD | €0.98 1.07 USD | €628.86M 687.43M USD | 0 | -€0.10 -0.1 USD | ||
| Valneva SE AYJ0.F | €6.95 7.6 USD |
-7.95
|
€627.33M 685.76M USD | €350.00 382.6 USD | €6.95 7.6 USD | €7.00 7.65 USD | €627.33M 685.76M USD | 0 | -€0.92 -1.005 USD | ||
| KalVista Pharmaceuticals, Inc. 4XC1.F | €11.50 12.57 USD |
+5.5
|
€602.26M 658.35M USD | €930.00 1.02K USD | €11.50 12.57 USD | €11.50 12.57 USD | €602.26M 658.35M USD | 0 | -€3.39 -3.7 USD | ||
| Takara Bio Inc. TF2.F | €4.34 4.74 USD |
+1.88
|
€569.80M 622.87M USD | €200.00 218.63 USD | €4.34 4.74 USD | €4.34 4.74 USD | €569.80M 622.87M USD | 0 | -€0.29 -0.3 USD | ||
| CytomX Therapeutics, Inc. 6C1.F | €3.27 3.58 USD |
+0.74
|
€568.43M 621.37M USD | €1.42K 1.56K USD | €3.27 3.58 USD | €3.27 3.58 USD | €568.43M 621.37M USD | 12.58 | €0.26 0.28 USD | ||
| Gossamer Bio, Inc. 4GB.F | €2.24 2.45 USD |
+12.31
|
€562.93M 615.36M USD | €100.00 109.31 USD | €2.24 2.45 USD | €2.24 2.45 USD | €562.93M 615.36M USD | 0 | -€0.59 -0.6 USD | ||
| REGENXBIO Inc. RB0.F | €9.90 10.82 USD |
+1.54
|
€516.20M 564.28M USD | €700.00 765.19 USD | €9.90 10.82 USD | €9.90 10.82 USD | €516.20M 564.28M USD | 0 | -€2.98 -3.2 USD | ||
| Opthea Limited UKJ2.F | €3.00 3.28 USD |
0
|
€512.99M 560.77M USD | €0.00 0 USD | €3.00 3.28 USD | €3.00 3.28 USD | €512.99M 560.77M USD | 0 | -€1.94 -2.1 USD | ||
| Inventiva S.A. 6IV.F | €3.28 3.59 USD |
+7.36
|
€512.54M 560.28M USD | €500.00 546.57 USD | €3.28 3.59 USD | €3.28 3.59 USD | €512.54M 560.28M USD | 0 | -€3.76 -4.1 USD | ||
| Inventiva S.A. 6IVA.F | €3.20 3.5 USD |
+3.9
|
€495.98M 542.18M USD | €4.00K 4.37K USD | €3.20 3.5 USD | €3.20 3.5 USD | €495.98M 542.18M USD | 0 | -€3.76 -4.1 USD | ||
| Viva Biotech Holdings VB0.F | €0.22 0.24 USD |
-6.03
|
€479.75M 524.44M USD | €5.78K 6.32K USD | €0.22 0.24 USD | €0.22 0.24 USD | €479.75M 524.44M USD | 21.80 | €0.01 0.01 USD | ||
| Niagen Bioscience, Inc. OCD1.F | €5.65 6.18 USD |
-0.88
|
€477.06M 521.49M USD | €1.20K 1.31K USD | €5.65 6.18 USD | €5.65 6.18 USD | €477.06M 521.49M USD | 26.90 | €0.21 0.23 USD | ||
| Prothena Corporation plc 0PT.F | €8.45 9.24 USD |
+0.6
|
€475.59M 519.89M USD | €24.00 26.24 USD | €8.45 9.24 USD | €8.45 9.24 USD | €475.59M 519.89M USD | 0 | -€4.47 -4.8 USD | ||
| Omeros Corporation 3O8.F | €6.99 7.64 USD |
+6.16
|
€475.37M 519.64M USD | €394.00 430.7 USD | €6.84 7.47 USD | €7.05 7.71 USD | €475.37M 519.64M USD | 0 | -€2.03 -2.2 USD | ||
| Opthea Limited UKJ.F | €0.32 0.35 USD |
0
|
€437.75M 478.52M USD | €7.00K 7.65K USD | €0.32 0.35 USD | €0.32 0.35 USD | €437.75M 478.52M USD | 0 | -€0.25 -0.2 USD | ||
| Zevra Therapeutics, Inc. 1GDA.F | €7.55 8.25 USD |
-3.21
|
€433.94M 474.35M USD | €10.00 10.93 USD | €7.55 8.25 USD | €7.55 8.25 USD | €433.94M 474.35M USD | 18.87 | €0.40 0.44 USD | ||
| Nxera Pharma Co., Ltd. JSS.F | €4.68 5.12 USD |
0
|
€428.40M 468.29M USD | €400.00 437.25 USD | €4.68 5.12 USD | €4.68 5.12 USD | €428.40M 468.29M USD | 0 | -€0.20 -0.2 USD | ||
| Formycon AG FYB.F | €22.80 24.92 USD |
+11.22
|
€424.36M 463.88M USD | €1.26K 1.38K USD | €22.50 24.6 USD | €22.80 24.92 USD | €424.36M 463.88M USD | 0 | -€9.67 -10.5 USD | ||
| NovaBridge Biosciences 0VY.F | €3.52 3.85 USD |
+0.57
|
€417.06M 455.9M USD | €3.52K 3.85K USD | €3.52 3.85 USD | €3.52 3.85 USD | €417.06M 455.9M USD | 0 | -€0.44 -0.4 USD | ||
| DBV Technologies S.A. DBV.F | €2.25 2.45 USD |
-4.47
|
€403.52M 441.1M USD | €2.20K 2.4K USD | €2.25 2.45 USD | €2.25 2.45 USD | €403.52M 441.1M USD | 0 | -€0.89 -0.9 USD | ||
| Bicycle Therapeutics plc 50BA.F | €5.45 5.96 USD |
+0.93
|
€398.65M 435.78M USD | €315.00 344.34 USD | €5.40 5.9 USD | €5.45 5.96 USD | €398.65M 435.78M USD | 0 | -€3.11 -3.3 USD | ||
| Avacta Group Plc RTQ1.F | €0.88 0.96 USD |
-2.76
|
€389.22M 425.47M USD | €6.00K 6.56K USD | €0.88 0.96 USD | €0.88 0.96 USD | €389.22M 425.47M USD | 0 | -€0.12 -0.1 USD | ||
| Akebia Therapeutics, Inc. AX9.F | €1.42 1.55 USD |
-5.46
|
€380.94M 416.42M USD | €500.00 546.57 USD | €1.42 1.55 USD | €1.42 1.55 USD | €380.94M 416.42M USD | 0 | -€0.07 -0.07 USD | ||
| Anavex Life Sciences Corp. 12X1.F | €2.84 3.1 USD |
-9.73
|
€380.64M 416.1M USD | €6.03K 6.59K USD | €2.84 3.1 USD | €2.84 3.1 USD | €380.64M 416.1M USD | 0 | -€0.49 -0.5 USD | ||
| Altimmune, Inc. 3G0.F | €3.47 3.79 USD |
+1.64
|
€371.49M 406.09M USD | €300.00 327.94 USD | €3.47 3.79 USD | €3.47 3.79 USD | €371.49M 406.09M USD | 0 | -€0.92 -1.005 USD | ||
| XOMA Royalty Corporation X0M1.F | €28.00 30.61 USD |
+5.26
|
€362.56M 396.33M USD | €13.00 14.21 USD | €27.80 30.39 USD | €28.00 30.61 USD | €362.56M 396.33M USD | 43.75 | €0.64 0.7 USD | ||
| Cellectis S.A. ZVAA.F | €3.32 3.63 USD |
+8.5
|
€349.41M 381.95M USD | €1.86K 2.03K USD | €3.32 3.63 USD | €3.32 3.63 USD | €349.41M 381.95M USD | 0 | -€0.28 -0.3 USD | ||
| Cellectis S.A. ZVA.F | €3.38 3.69 USD |
+6.8
|
€343.96M 375.99M USD | €1.25K 1.37K USD | €3.38 3.69 USD | €3.38 3.69 USD | €343.96M 375.99M USD | 0 | -€0.28 -0.3 USD | ||
| PureTech Health plc 0VQ0.F | €12.80 13.99 USD |
-1.54
|
€337.42M 368.84M USD | €0.00 0 USD | €12.80 13.99 USD | €12.80 13.99 USD | €337.42M 368.84M USD | 8.76 | €1.46 1.6 USD | ||
| Flerie AB (publ) 1NP.F | €4.16 4.55 USD |
+1.96
|
€325.60M 355.93M USD | €1.00 1.09 USD | €4.03 4.41 USD | €4.14 4.53 USD | €325.60M 355.93M USD | 0 | -€8.83 -9.6 USD | ||
| Newron Pharmaceuticals S.p.A. NP5.F | €16.04 17.53 USD |
+0.12
|
€325.00M 355.27M USD | €4.00K 4.37K USD | €16.04 17.53 USD | €16.04 17.53 USD | €325.00M 355.27M USD | 11.79 | €1.36 1.49 USD | ||
| Autolus Therapeutics plc 6A3A.F | €1.17 1.28 USD |
+8.33
|
€318.40M 348.05M USD | €2.25K 2.46K USD | €1.17 1.28 USD | €1.17 1.28 USD | €318.40M 348.05M USD | 0 | -€0.71 -0.7 USD | ||
| Clinuvel Pharmaceuticals Limited UR9A.F | €5.95 6.5 USD |
+0.85
|
€315.45M 344.83M USD | €1.68K 1.84K USD | €5.95 6.5 USD | €5.95 6.5 USD | €315.45M 344.83M USD | 14.87 | €0.40 0.44 USD | ||
| Clinuvel Pharmaceuticals Limited UR9.F | €6.20 6.78 USD |
+0.81
|
€315.34M 344.71M USD | €1.02K 1.11K USD | €6.20 6.78 USD | €6.20 6.78 USD | €315.34M 344.71M USD | 15.49 | €0.40 0.44 USD | ||
| Galectin Therapeutics Inc. PHPN.F | €4.68 5.12 USD |
+1.3
|
€311.63M 340.65M USD | €2.00K 2.19K USD | €4.68 5.12 USD | €4.68 5.12 USD | €311.63M 340.65M USD | 0 | -€0.55 -0.6 USD | ||
| Antengene Corporation Limited 722.F | €0.48 0.53 USD |
-6.02
|
€309.14M 337.93M USD | €103.00 112.59 USD | €0.48 0.53 USD | €0.48 0.53 USD | €309.14M 337.93M USD | 0 | -€0.04 -0.04 USD | ||
| Silence Therapeutics plc XRP2.F | €6.50 7.11 USD |
+15.04
|
€307.02M 335.62M USD | €50.00 54.66 USD | €6.50 7.11 USD | €6.50 7.11 USD | €307.02M 335.62M USD | 0 | -€1.16 -1.2 USD | ||
| Rocket Pharmaceuticals, Inc. 9IP1.F | €2.55 2.79 USD |
+1.23
|
€299.62M 327.53M USD | €7.90K 8.64K USD | €2.55 2.79 USD | €2.55 2.79 USD | €299.62M 327.53M USD | 0 | -€1.93 -2.1 USD | ||
| Enanta Pharmaceuticals, Inc. 9EP.F | €10.20 11.15 USD |
0
|
€294.30M 321.71M USD | €54.00 59.03 USD | €10.20 11.15 USD | €10.20 11.15 USD | €294.30M 321.71M USD | 0 | -€3.71 -4.05 USD | ||
| Healios K.K. 6VX.F | €2.42 2.65 USD |
-1.63
|
€291.85M 319.04M USD | €350.00 382.6 USD | €2.42 2.65 USD | €2.42 2.65 USD | €291.85M 319.04M USD | 0 | -€0.34 -0.3 USD | ||
| AC Immune SA IMR.F | €2.76 3.02 USD |
-3.33
|
€277.66M 303.52M USD | €1.30K 1.42K USD | €2.60 2.84 USD | €2.76 3.02 USD | €277.66M 303.52M USD | 0 | -€0.78 -0.8 USD | ||
| scPharmaceuticals Inc. 2SX.F | €4.76 5.2 USD |
0
|
€261.18M 285.51M USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €261.18M 285.51M USD | 0 | €0.00 0 USD | ||
| Aldeyra Therapeutics, Inc. 137.F | €4.29 4.69 USD |
-0.51
|
€259.23M 283.38M USD | €540.00 590.29 USD | €4.29 4.69 USD | €4.29 4.69 USD | €259.23M 283.38M USD | 0 | -€0.63 -0.6 USD | ||
| Onward Medical N.V. 63E.F | €4.21 4.6 USD |
+8.52
|
€258.00M 282.03M USD | €140.00 153.04 USD | €4.20 4.59 USD | €4.40 4.81 USD | €258.00M 282.03M USD | 0 | -€0.74 -0.8 USD | ||
| Larimar Therapeutics, Inc. ZA71.F | €2.88 3.15 USD |
+3.6
|
€251.68M 275.12M USD | €510.00 557.5 USD | €2.88 3.15 USD | €2.88 3.15 USD | €251.68M 275.12M USD | 0 | -€1.69 -1.8 USD | ||
| Mereo BioPharma Group plc MAH0.F | €1.53 1.67 USD |
+1.33
|
€242.68M 265.28M USD | €600.00 655.88 USD | €1.53 1.67 USD | €1.53 1.67 USD | €242.68M 265.28M USD | 0 | -€0.21 -0.2 USD | ||
| Oryzon Genomics S.A. ORN.F | €3.00 3.28 USD |
+1.18
|
€239.75M 262.08M USD | €50.00 54.66 USD | €3.00 3.28 USD | €3.00 3.28 USD | €239.75M 262.08M USD | 0 | -€0.06 -0.06 USD | ||
| Hansa Biopharma AB (publ) 24H.F | €2.30 2.52 USD |
-2.54
|
€239.22M 261.5M USD | €517.00 565.15 USD | €2.30 2.52 USD | €2.30 2.52 USD | €239.22M 261.5M USD | 0 | -€0.83 -0.9 USD | ||
| Avalo Therapeutics Inc. R C6K0.F | €12.82 14.01 USD |
+3.22
|
€237.87M 260.03M USD | €4.00 4.37 USD | €12.82 14.01 USD | €12.82 14.01 USD | €237.87M 260.03M USD | 0 | -€11.53 -12.6 USD | ||
| Egetis Therapeutics AB (publ) P0F.F | €0.55 0.61 USD |
-2.46
|
€232.16M 253.78M USD | €20.00K 21.86K USD | €0.55 0.61 USD | €0.55 0.61 USD | €232.16M 253.78M USD | 0 | -€0.09 -0.09 USD | ||
| Capricor Therapeutics, Inc. 4LN2.F | €4.73 5.17 USD |
+0.64
|
€229.04M 250.37M USD | €200.00 218.63 USD | €4.73 5.17 USD | €4.73 5.17 USD | €229.04M 250.37M USD | 0 | -€1.50 -1.6 USD | ||
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
|||||||||||
- {{ link.label }} {{link}}